Correlation Between Virax Biolabs and Histogen
Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Histogen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Histogen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virax Biolabs Group and Histogen, you can compare the effects of market volatilities on Virax Biolabs and Histogen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Histogen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Histogen.
Diversification Opportunities for Virax Biolabs and Histogen
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Virax and Histogen is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Histogen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Histogen and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Histogen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Histogen has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Histogen go up and down completely randomly.
Pair Corralation between Virax Biolabs and Histogen
Given the investment horizon of 90 days Virax Biolabs Group is expected to generate 0.33 times more return on investment than Histogen. However, Virax Biolabs Group is 3.07 times less risky than Histogen. It trades about -0.03 of its potential returns per unit of risk. Histogen is currently generating about -0.3 per unit of risk. If you would invest 221.00 in Virax Biolabs Group on August 29, 2024 and sell it today you would lose (19.00) from holding Virax Biolabs Group or give up 8.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virax Biolabs Group vs. Histogen
Performance |
| Timeline |
| Virax Biolabs Group |
| Histogen |
Virax Biolabs and Histogen Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virax Biolabs and Histogen
The main advantage of trading using opposite Virax Biolabs and Histogen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Histogen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Histogen will offset losses from the drop in Histogen's long position.| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals | Virax Biolabs vs. Seres Therapeutics |
| Histogen vs. Eliem Therapeutics | Histogen vs. Scpharmaceuticals | Histogen vs. Milestone Pharmaceuticals | Histogen vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |